Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Clinical and Experimental Nephrology|March 23, 2018
The features in IgA-dominant infection-related glomerulonephritis distinct from IgA nephropathy: a single-center studyTakaya Handa, Hiroko Kakita, Yu Tateishi, et al.
Clinical and Experimental Nephrology|January 5, 2008
Nephronophthisis complicated with hepatic fibrosis: an autopsy case with rupture of the splenic artery after renal transplantationTatsuo Tsukamoto, Mari Tanaka, Toshiyuki Komiya, et al.
Clinical and Experimental Nephrology|December 19, 2007
MPO-ANCA-positive IgA nephropathy successfully treated with tonsillectomyNoriko Ogawa, Shozo Yano, Yuko Yamane, et al.
Nephrology (Carlton, Vic.)|January 24, 2015
Gender- and disease-specific urinary thioredoxin in chronic kidney disease patients with or without type 2 diabetic nephropathyKyoko Tobino, Eri Muso, Yukako Iwasaki, et al.
The Journal of Pathology|September 18, 2004
Role of mesangial Factor V expression in crescent formation in rat experimental mesangioproliferative glomerulonephritisTakahiko Ono, Ning Liu, Toshiaki Makino, et al.
Nephron. Clinical Practice|April 25, 2009
Impact of obesity on IgA nephropathy: comparative ultrastructural study between obese and non-obese patientsMari Tanaka, Sachiko Yamada, Yukako Iwasaki, et al.
International Urology and Nephrology|June 3, 2024
Serum IgA/C3 ratio: a useful marker of disease activity in patients with IgA nephropathyKazuo Torikoshi, Tomomi Endo, Tatsuo Tsukamoto, et al.
American Journal of Physiology. Renal Physiology|June 3, 2004
Coagulation in the mesangial area promotes ECM accumulation through factor V expression in MsPGN in ratsNing Liu, Toshiaki Makino, Fumiaki Nogaki, et al.
Contributions to Nephrology|May 15, 2007
Clinicopathological influence of obesity in IgA nephropathy: comparative study of 74 patientsMari Tanaka, Tomomi Tsujii, Toshiyuki Komiya, et al.
Pageof 11